Related Experiment Videos
First trimester Down syndrome screening: public health implications.
Karin M Fuchs1, Jeffrey F Peipert
1Department of Obstetrics and Gynecology, Women and Infants' Hospital, Brown University Medical School, Providence, RI 02905, USA.
Seminars in Perinatology
|August 18, 2005
Summary
First-trimester Down syndrome (DS) screening using nuchal translucency and serum markers improves prenatal diagnostics. Challenges in access and quality control require continued focus on patient education and provider training for effective implementation.
Area of Science:
- Prenatal diagnostics
- Genetics
- Maternal-fetal medicine
Background:
- Down syndrome (DS) screening is a standard prenatal procedure.
- Advancements focus on non-invasive methods for earlier detection and intervention.
- First-trimester screening aims to enhance sensitivity and diagnostic capabilities.
Purpose of the Study:
- To evaluate the effectiveness of first-trimester Down syndrome screening methods.
- To identify challenges and requirements for implementing advanced prenatal screening.
- To emphasize the importance of quality control, patient education, and provider training.
Main Methods:
- Utilizing nuchal translucency ultrasound measurements.
- Incorporating serum markers such as hCG and pregnancy-associated plasma protein A (PAPP-A).
- Combining ultrasound and biochemical markers for risk assessment in the first and/or second trimester.
Main Results:
- Nuchal translucency combined with serum markers improves diagnostic accuracy for Down syndrome.
- First-trimester screening offers earlier diagnostic and interventional opportunities.
- Operational issues like access and availability may hinder widespread adoption.
Conclusions:
- First-trimester Down syndrome screening enhances prenatal diagnostic capabilities.
- Standardized quality control systems are crucial for reliable results.
- Improved access, provider education, and patient counseling are essential for successful implementation.